Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 160,000 | reported | 02 Mar 2026 | tx 10+990,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 29 May 2025 | PURCHASE | Nautilus Biotechnology, Inc. | 15,000 | 0.77 USD | first after silence |
| 03 Mar 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 27 Feb 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 19 Aug 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 17,500 | 2.30 USD | |
| 27 Jun 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 5,500 | 2.75 USD | |
| 25 Feb 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 280,000 | 0.00 USD | deriv |
| 24 Nov 2021 | PURCHASE | Nautilus Biotechnology, Inc. | 15,000 | 4.58 USD | |
| 12 Aug 2021 | PURCHASE | Nautilus Biotechnology, Inc. | 17,500 | 7.71 USD |
1 purchase reported after at least 12 months of silence — most recent on 29 May 2025.